Evidence map›Paper›PMID 39940683›Full record

ArticleInternational journal of molecular sciences2025

Deciphering the Association: Critical HDL-C Levels and Their Impact on the Glycation Gap in People Living with HIV.

Elsa J Anaya-Ambriz, Monserrat Alvarez-Zavala, Luz A González-Hernández, Jaime F Andrade-Villanueva, Sergio Zuñiga-Quiñones, Adriana Valle-Rodríguez, Tania E Holguin-Aguirre, Karina Sánchez-Reyes

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Glycemic control among People living with HIV and diabetes in Eastern Uganda: A cross-sectional study.Nigerian medical journal : journal of the Nigeria Medical Association
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elsa J Anaya-AmbrizPrograma de Doctorado en Microbiología Médica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0001-9384-201X
Monserrat Alvarez-ZavalaDepartamento de Clínicas Médicas, Instituto de Investigación en Inmunodeficiencias y VIH, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44350, Mexico.
Luz A González-HernándezDepartamento de Clínicas Médicas, Instituto de Investigación en Inmunodeficiencias y VIH, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44350, Mexico.ORCID 0000-0002-7163-0566
Jaime F Andrade-VillanuevaDepartamento de Clínicas Médicas, Instituto de Investigación en Inmunodeficiencias y VIH, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44350, Mexico.ORCID 0000-0003-1948-655X
Sergio Zuñiga-QuiñonesUnidad de VIH, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44350, Mexico.
Adriana Valle-RodríguezUnidad de VIH, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44350, Mexico.
Tania E Holguin-AguirreUnidad de VIH, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44350, Mexico.
Karina Sánchez-ReyesDepartamento de Clínicas Médicas, Instituto de Investigación en Inmunodeficiencias y VIH, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44350, Mexico.ORCID 0000-0001-6839-0293

Funding

Universidad de Guadalajara, Centro Universitario de Ciencias de Salud (CUCS-UDG). PIN 2021-II
6 · The paper itself

Abstract

People Living with HIV (PLWHIV) present an increased risk of developing non-communicable diseases, such as type 2 diabetes (T2D), making it crucial to optimize glycemic control and assess metabolic markers. HbA1c is considered the gold standard for evaluating glycemic control, while fructosamine (FA) offers advantages in assessing non-glycemic determinants. Discrepancies between HbA1c and FA are common and may be influenced by temporal factors. The Glycation Gap (G-gap) emerges as a tool to clarify these discrepancies. A cross-sectional analytical study was conducted involving PLWHIV with various glycemic statuses, as well as patients with T2D and controls. Sociodemographic data were collected along with blood samples to measure biochemical profiles and FA. HbA1c predicted from FA (pHbA1c) was calculated using a linear regression equation, facilitating G-gap determination. A positive correlation was found between G-gap and levels of VLDL-C and triglycerides (TG). Additionally, a negative correlation was observed between HDL-C levels < 40 mg/dL and a positive G-gap. These associations suggest that the G-gap may be a useful tool for metabolic evaluation in PLWHIV and a preventive method for identifying individuals at risk of developing chronic complications related to T2D.

Indexed as

Cholesterol, HDLDiabetes Mellitus, Type 2HIV InfectionsAdultBiomarkersBlood GlucoseCross-Sectional StudiesFemaleFructosamineGlycated HemoglobinGlycosylationHumansMaleMiddle AgedTriglyceridesBiomarkersBlood GlucoseCholesterol, HDLFructosamineGlycated Hemoglobinhemoglobin A1c protein, humanTriglyceridesdyslipidemiafructosamineG-gapHbA1cHIVT2D

Identifiers

PMID39940683
PMCPMC11817432

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.